TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $103,000 | +5050.0% | 17,406 | +3667.5% | 0.00% | – |
| Q2 2022 | $2,000 | -98.0% | 462 | -91.1% | 0.00% | -100.0% |
| Q4 2021 | $99,000 | +76.8% | 5,186 | +256.2% | 0.00% | +50.0% |
| Q2 2021 | $56,000 | +1766.7% | 1,456 | +464.3% | 0.00% | +100.0% |
| Q1 2020 | $3,000 | -85.0% | 258 | -85.9% | 0.00% | -80.0% |
| Q4 2019 | $20,000 | 0.0% | 1,829 | -49.7% | 0.01% | -28.6% |
| Q3 2018 | $20,000 | -4.8% | 3,637 | -18.9% | 0.01% | -66.7% |
| Q4 2016 | $21,000 | – | 4,485 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |